Publication
Osteoarticular Infections in Infants Under 3 Months of Age
dc.contributor.author | Branco, J | |
dc.contributor.author | Duarte, M | |
dc.contributor.author | Norte, S | |
dc.contributor.author | Arcangelo, J | |
dc.contributor.author | Alves, P | |
dc.contributor.author | Brito, M | |
dc.contributor.author | Tavares, D | |
dc.contributor.author | Gouveia, C | |
dc.date.accessioned | 2023-05-04T11:56:49Z | |
dc.date.available | 2023-05-04T11:56:49Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Pediatr Int . 2022 Jan;64(1):e15212 | pt_PT |
dc.identifier.doi | 10.1111/ped.15212 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4508 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.subject | Adolescent | pt_PT |
dc.subject | Anti-Bacterial Agents / therapeutic use | pt_PT |
dc.subject | Bacteremia* / microbiology | pt_PT |
dc.subject | Child | pt_PT |
dc.subject | Cross Infection* / drug therapy | pt_PT |
dc.subject | Infant | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Methicillin-Resistant Staphylococcus aureus* | pt_PT |
dc.subject | Osteomyelitis* / diagnosis | pt_PT |
dc.subject | Osteomyelitis* / epidemiology | pt_PT |
dc.subject | Osteomyelitis* / therapy | pt_PT |
dc.subject | Retrospective Studies | pt_PT |
dc.subject | Staphylococcal Infections* / diagnosis | pt_PT |
dc.subject | Staphylococcal Infections* / drug therapy | pt_PT |
dc.subject | Staphylococcal Infections* / epidemiology | pt_PT |
dc.subject | Staphylococcus aureus | pt_PT |
dc.subject | HDE INF PED | pt_PT |
dc.subject | HDE ORT PED | pt_PT |
dc.subject | HDE IMA | pt_PT |
dc.title | Osteoarticular Infections in Infants Under 3 Months of Age | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.issue | 1 | pt_PT |
oaire.citation.startPage | e15212 | pt_PT |
oaire.citation.title | Pediatrics International | pt_PT |
oaire.citation.volume | 64 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |